Procyon Advisors’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$475K Buy
461,188
+20,450
+5% +$26K 0.02% 369
2026
Q2
$674K Buy
440,738
+1,800
+0.4% +$2.74K 0.03% 320
2026
Q1
$794K Buy
438,938
+214,838
+96% +$371K 0.04% 291
2025
Q4
$303K Buy
224,100
+13,000
+6% +$18.5K 0.01% 435
2025
Q3
$344K Buy
211,100
+11,000
+5% +$12.2K 0.02% 381
2025
Q2
$194K Buy
+200,100
New +$166K 0.02% 455

Other funds holding OCGN

Procyon Advisors's OCGN Position: Q3 2026 in Review

Procyon Advisors increased its Ocugen (OCGN) stake by 4.6% in Q3 2026, buying an estimated $26K and bringing the position to 461,188 shares worth $475K. The position accounts for 0.02% of the portfolio, ranked #369.

Procyon Advisors first reported a position in OCGN in Q2 2025 and has held it in 6 quarters since. The position peaked at $794K in Q1 2026. 52 funds tracked by Wall St. Rank hold OCGN as of Q3 2026.

  • Procyon Advisors held 461,188 shares of Ocugen worth $475K as of Q3 2026.
  • Procyon Advisors bought 20,450 Ocugen shares in Q3 2026, an estimated $26K.
  • Ocugen made up 0.02% of Procyon Advisors's portfolio in Q3 2026, its #369 holding.
  • Procyon Advisors first reported a position in Ocugen in Q2 2025 and has held it in 6 quarters since.
  • Procyon Advisors's Ocugen position peaked at $794K in Q1 2026.
  • 52 funds tracked by Wall St. Rank held Ocugen as of Q3 2026.

Based on Procyon Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.